Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ICAM-1 orchestrates radiotherapy abscopal effect

April 23, 2021

Tolremo Therapeutics describes new DYRK1B inhibitors

April 23, 2021

Shanghai Litedd identifies new ROR-gammaT agonists

April 23, 2021

Chinese investigators disclose HGFR and/or SRC and/or CSF1R inhibitors

April 23, 2021

Monopteros initiates phase I/Ib study of MPT-0118 in solid tumors

April 23, 2021

First patient dosed in investigator-initiated study of rigosertib in RDEB-associated SCC

April 23, 2021

Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807

April 23, 2021

Boragen identifies new JAK inhibitors

April 22, 2021

Nirogyone Therapeutics discloses MCT inhibitors

April 22, 2021

Dosing starts in phase I study of AL-102 in combination with WVT-078 in patients with MM

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...